FDA Approves Newly Revised Prescribing Information For AZILECT(R) Reducing Medication And Food Restrictions
Links shared publicly online about this topic.
- 1,528total visits
FDA Approves Newly Revised Prescribing Information For AZILECT(R) Reducing Medication And Food Restrictions
View full resource at medicalnewstoday.com
Tags: Drug, Pharma, FDA, Teva Pharmaceutical Industries
Most Recently Shared on December 15, 2009 at 9:41 pm By:
FDA Approves Newly Revised Prescribing Information For AZILECT(R) Reducing Medication And Food Restrictions http://ow.ly/169XHB
Also Shared By:
FDA Approves Newly Revised Prescribing Information for Azilect Reducing Medication and Food Restrictions
drugs.com — “Azilect (rasagiline) is used for Parkinson’s Disease. Information from Drugs.com includes Azilect side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on December 15, 2009 at 10:13 pm By:
FDA Approves New Prescribing Information for Azilect Reducing Medication and Food Restrictions - http://bit.ly/8BJT52
Teva Pharmaceutical Industries receives approval for newly revised prescribing information for AZILECT
news-medical.net — “Teva Pharmaceutical Industries, Ltd. today announced the U.S. Food and Drug Administration (FDA) approved the newly revised prescribing information for AZILECT® (rasagiline tablets) reducing medication and food restrictions.” View full resource at news-medical.net
Most Recently Shared on December 15, 2009 at 9:57 pm By:
Parkinson's Disease: Teva Pharmaceutical Industries receives approval for newly revised prescribing information for... http://bit.ly/4A228i
Advertisement
MNT Parkinson's News
@mnt_parkinsons
FDA Approves Newly Revised Prescribing Information For AZILECT(R) Reducing Medication And Food Restrictions http://mnt.to/3vwn
1 year ago...